EKF Diagnostics Holdings plc
EKDHFOTCHealthcare● Active
$0.39
+$0.04(+12.42%)
Market Cap$167896214
P/E Ratio—
52W High$0.42365
52W Low$0.2939
EKF Diagnostics Holdings plc (EKDHF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
EKDHF · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 24, 2026EPS Actual
$0.01
Est. $0.01 · +0.0%
Revenue
$0.04B
Est. $0.04B · +0.0%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 24, 2026
After Market Close
✓ 1-Quarter EPS Beat Streak
EKDHF reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 22, 2026 | $0.01 | — | — | — | $0.03B | — |
| — Q1 FY2026 | Mar 24, 2026 | $0.01 | $0.01 | +0.0% | $0.04B | $0.04B | +0.0% |
| ▼ Q3 FY2025 | Sep 16, 2025 | $0.01 | $0.01 | -14.0% | $0.03B | $0.03B | +0.1% |
| ◌ Q2 FY2025 | May 14, 2025 | — | — | — | — | — | — |
| ▲ Q1 FY2025 | Mar 25, 2025 | $0.01 | $0.01 | +83.9% | $0.03B | $0.03B | +0.2% |
| ◌ Q1 FY2025 | Mar 18, 2025 | — | — | — | — | — | — |
| ▼ Q3 FY2024 | Sep 17, 2024 | $0.01 | $0.01 | -8.9% | $0.03B | $0.03B | -3.0% |
| ◌ Q2 FY2024 | May 14, 2024 | — | — | — | — | — | — |
Q3 FY2026
Sep 22, 2026
EPS Actual
—
EPS Est.
$0.01
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 24, 2026
EPS Actual
$0.01
EPS Est.
$0.01
EPS Surpr.
+0.0%
Revenue
$0.04B
Q3 FY2025
Sep 16, 2025Miss
EPS Actual
$0.01
EPS Est.
$0.01
EPS Surpr.
-14.0%
Revenue
$0.03B
Q2 FY2025
May 14, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 25, 2025Beat
EPS Actual
$0.01
EPS Est.
$0.01
EPS Surpr.
+83.9%
Revenue
$0.03B
Q1 FY2025
Mar 18, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Sep 17, 2024Miss
EPS Actual
$0.01
EPS Est.
$0.01
EPS Surpr.
-8.9%
Revenue
$0.03B
Q2 FY2024
May 14, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q1 FY2026 | Mar 24, 2026 | +0.0% | $0.34 | $0.34 | +0.00% |
| ▼ Q3 FY2025 | Sep 16, 2025 | -14.0% | $0.42 | $0.42 | +0.00% |
| ▲ Q1 FY2025 | Mar 25, 2025 | +83.9% | $0.36 | $0.36 | +0.00% |
| ▼ Q3 FY2024 | Sep 17, 2024 | -8.9% | $0.36 | $0.36 | +0.00% |
| ▼ Q1 FY2024 | Mar 20, 2024 | -57.3% | $0.31 | $0.31 | +0.00% |
| — Q4 FY2023 | Dec 30, 2023 | — | $0.31 | $0.31 | +0.00% |
| — Q2 FY2023 | Jun 29, 2023 | — | $0.31 | $0.31 | +0.00% |
| ▼ Q1 FY2023 | Mar 31, 2023 | -106.2% | $0.33 | $0.33 | +0.00% |
Q1 FY2026+0.00%
Report Date
Mar 24, 2026
EPS Beat/Miss
+0.0%
Price Before
$0.34
Price After
$0.34
Q3 FY2025+0.00%
Report Date
Sep 16, 2025
EPS Beat/Miss
-14.0%
Price Before
$0.42
Price After
$0.42
Q1 FY2025+0.00%
Report Date
Mar 25, 2025
EPS Beat/Miss
+83.9%
Price Before
$0.36
Price After
$0.36
Q3 FY2024+0.00%
Report Date
Sep 17, 2024
EPS Beat/Miss
-8.9%
Price Before
$0.36
Price After
$0.36
Q1 FY2024+0.00%
Report Date
Mar 20, 2024
EPS Beat/Miss
-57.3%
Price Before
$0.31
Price After
$0.31
Q4 FY2023+0.00%
Report Date
Dec 30, 2023
EPS Beat/Miss
—
Price Before
$0.31
Price After
$0.31
Q2 FY2023+0.00%
Report Date
Jun 29, 2023
EPS Beat/Miss
—
Price Before
$0.31
Price After
$0.31
Q1 FY2023+0.00%
Report Date
Mar 31, 2023
EPS Beat/Miss
-106.2%
Price Before
$0.33
Price After
$0.33
Avg Beat Reaction+0.00%
Avg Miss Reaction+0.00%
Beat Rate2 / 8 quarters
Largest Move+0.00% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: EKDHF ends December
EKF Diagnostics Holdings plc (EKDHF) most recently reported earnings on March 24, 2026 for Q1 FY2026, posting EPS of $0.01 (in line with the analyst consensus of $0.01). The next EKDHF earnings date is expected around September 1, 2026.
Each quarter, investors track EKDHF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EKDHF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
EKDHF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
EKDHF earnings · 4 questionsEKF Diagnostics Holdings plc's next earnings report is expected around September 1, 2026. EKDHF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EKDHF historically reports after market close (AMC).
EKDHF earnings datewhen is EKDHF earningsEKDHF next earnings datewhen does EKDHF report earningsEKDHF earnings calendar
▸ Source: FMP · EKF Diagnostics Holdings plc SEC filings · US GAAP · EKF Diagnostics Holdings plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026